Ropes & Gray has advised Novanta. Novanta Inc. (NASDAQ: NOVT) has entered into a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for an...
Novanta Acquires Riverpoint Medical for Up to $1.45 Billion
Kailera Therapeutics Raises $600 Million in Series B Financing
Ropes & Gray has advised Bain Capital on the transaction. Kailera Therapeutics, a clinical-stage biopharmaceutical company specializing in obesity therapies, has announced the closing of a...
Gero and Chugai Enter Agreement to Develop Antibody Therapies for Age-Related Diseases
Ropes & Gray has advised Gero on the transaction. Gero PTE. LTD., a biotechnology company headquartered in Singapore, and Chugai Pharmaceutical Co., Ltd., based in Tokyo,...
Sanofi and EQT Life Sciences Invest in SpliceBio’s $135 Million Series B Financing
Ropes & Gray has advised Sanofi and EQT Life Sciences on the transaction. Sanofi and EQT Life Sciences have participated in a $135 million Series B...
Partners Group’s Acquisition of Majority Stake in Fairjourney Biologics
Ropes & Gray advised Partners Group on the transaction. Partners Group, one of the largest firms in the global private markets industry, announced its acquisition of...
Blackstone Life Sciences’ $750 Million Collaboration with Moderna
Ropes & Gray represented Blackstone Life Sciences in the transaction. Blackstone Life Sciences (NYSE:BX) (“Blackstone”) announced a collaboration with Moderna, Inc. (NASDAQ: MRNA, “Moderna”) through a development and...
Intrinsic Medicine’s Business Combination Agreement with Phoenix Biotech Acquisition Corp.
Ropes & Gray advised Intrinsic, while Goodwin Procter advised PBAX on the deal. Intrinsic Medicine, Inc., a therapeutics company leveraging human milk biology to transform Gut-Brain...
IDRx’s $122 Million Series A Financing
Ropes & Gray advised IDRx on the deal. Clinical stage precision cancer biopharmaceutical company IDRx announced licensing transactions with Germany-based Merck KGaA and Blueprint Medicines to...
ConvaTec Group’s Acquisition of Triad Life Sciences
Ropes & Gray represented ConvaTec Group in the transaction. ConvaTec Group, a global medical solutions company, executed its acquisition of medical device company, Triad Life Sciences. ...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...